November 01, 2025
According to market projections, the CRISPR technology sector is expected to grow from USD 5.72 billion in 2024 to USD 26.22 billion by 2034, reflecting a CAGR of 16.54%. In 2024, North America led the global CRISPR technology market, while Asia-Paci...
December 24, 2025
According to market projections, the CRISPR sector is expected to grow from USD 2.94 billion in 2024 to USD 8.58 billion by 2034, reflecting a CAGR of 11.24%. The market is growing due to rising demand for gene-editing therapies in genetic disorders ...
January 05, 2026
According to market projections, the CRISPR gene editing sector is expected to grow from USD 4.76 billion in 2025 to USD 18.89 billion by 2035, reflecting a CAGR of 14.77%. In 2024, North America led the CRISPR gene editing market, while Asia-Pacific...
November 01, 2025
According to market projections, the nonspecific endonuclease market size to capture US$ 424.58 mn in 2025 and is to soar US$ 641.37 mn by 2030. The nonspecific endonuclease market is growing, driven by demand in gene therapy and genetic engineering,...
November 01, 2025
According to market projections, the genome editing sector is expected to grow from USD 9.39 billion in 2024 to USD 44.95 billion by 2034, reflecting a CAGR of 16.95%. Applications in various industries promote the growth of the genome editing market...
October 08, 2025
Market insights predict, the pneumonia testing industry is expected to grow from USD 1.97 billion in 2024 to USD 3.85 billion by 2034, driven by a CAGR of 6.97%. The rising prevalence of pneumonia and the growing demand for early diagnosis drive the ...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com